Reduced plasma calcitonin gene-related peptide level identified in cluster headache: A prospective and controlled study
Cephalalgia · 2024-03 · 44 (3)
DOI: 10.1177/03331024231223970 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cephalalgia, online erschienen am 04.03.2024. Verfasst von Anja Sofie Petersen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Danish Headache Center, Department of Neurology, University of Copenhagen, Rigshospitalet-Glostrup, Glostrup, Denmark. Hauptthemen laut MEDLINE: Calcitonin Gene-Related Peptide, Cluster Headache. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Research foundation of the capital region of Denmark, TrygFonden.
Abstract (Originalsprache)
Background
The role of calcitonin gene-related peptide (CGRP) in the cyclic pattern of cluster headache is unclear. To acquire biological insight and to comprehend why only episodic cluster headache responds to CGRP monoclonal antibodies, we examined whether plasma CGRP changes between disease states (i.e. bout, remission and chronic) and controls.
Methods
The present study is a prospective case–control study. Participants with episodic cluster headache were sampled twice (bout and remission). Participants with chronic cluster headache and controls were sampled once. CGRP concentrations were measured in plasma with a validated radioimmunoassay.
Results
Plasma was collected from 201 participants diagnosed with cluster headache according to the International Classification of Headache Disorders, 3rd edition, and from 100 age- and sex-matched controls. Overall, plasma CGRP levels were significantly lower in participants with cluster headache compared to controls ( p < 0.05). In episodic cluster headache, CGRP levels were higher in bout than in remission (mean difference: 17.1 pmol/L, 95% confidence interval = 9.8–24.3, p < 0.0001). CGRP levels in bout were not different from chronic cluster headache ( p = 0.266).
Conclusions
Plasma CGRP is unsuitable as a diagnostic biomarker of cluster headache or its disease states. The identified reduced CGRP levels suggest that CGRPs role in cluster headache is highly complex and future investigations are needed into the modulation of CGRP and its receptors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Danish Headache Center, Department of Neurology, University of Copenhagen, Rigshospitalet-Glostrup, Glostrup, Denmark.
- Institute of Physiology and Pathophysiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
- Department of Clinical Physiology and Nuclear Medicine, Centre for Functional and Diagnostic Imaging and Research, University of Copenhagen, Hvidovre Hospital, Hvidovre, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, Glostrup, Denmark.
ORCID-Profile: Anja Sofie Petersen, Nunu Lund, Karl Meßlinger, Lisette Kogelman
Förderung
- Research foundation of the capital region of Denmark
- TrygFonden
Zitieren
APA
Petersen, A. S., Lund, N., Meßlinger, K., Christensen, S. L., Barloese, M., Jørgensen, N. R., Kogelman, L., & Jensen, R. H. (2024). Reduced plasma calcitonin gene-related peptide level identified in cluster headache: A prospective and controlled study. Cephalalgia, 44(3). https://doi.org/10.1177/03331024231223970
Vancouver
Petersen AS, Lund N, Meßlinger K, Christensen SL, Barloese M, Jørgensen NR, et al. Reduced plasma calcitonin gene-related peptide level identified in cluster headache: A prospective and controlled study. Cephalalgia. 2024;44(3). doi:10.1177/03331024231223970
BibTeX
@article{Petersen2024,
author = {Petersen, Anja Sofie and Lund, Nunu and Meßlinger, Karl and Christensen, Sarah Louise and Barloese, Mads and Jørgensen, Niklas Rye and Kogelman, Lisette and Jensen, Rigmor Højland},
title = {Reduced plasma calcitonin gene-related peptide level identified in cluster headache: A prospective and controlled study},
journal = {Cephalalgia},
year = {2024},
volume = {44},
number = {3},
doi = {10.1177/03331024231223970}
}
EUVIMED